Trial intelligence / Profile preview

ALLIANCE: Vitamin C in COVID-19

NCT04395768Phase 2Unknown

Sponsor
National Institute of Integrative Medicine
Start
Sep 2020
Primary completion
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of ascorbic acid in coronavirus disease 2019 (COVID-19), sponsored by National Institute of Integrative Medicine. Status: unknown.

02

Drugs

ascorbic acid
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04395768.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04395768.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call